-
Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals’ Patent -
Novartis Reports Zolgensma Caused 2 Deaths From Liver Failure
-
Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma
-
Novartis to Cut Up to 8,000 Jobs Globally
-
Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
-
Novartis Says US Court Upholds Gilenya Patent
-
Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
-
Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
-
Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
-
Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
-
Novartis Korea Executives Charged With Bribing Doctors
-
New Drug Could Reduce Cardiovascular Deaths (Video)
